455 related articles for article (PubMed ID: 34669199)
1. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.
Berek JS; Renz M; Kehoe S; Kumar L; Friedlander M
Int J Gynaecol Obstet; 2021 Oct; 155 Suppl 1(Suppl 1):61-85. PubMed ID: 34669199
[TBL] [Abstract][Full Text] [Related]
2. Cancer of the ovary, fallopian tube, and peritoneum.
Berek JS; Kehoe ST; Kumar L; Friedlander M
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():59-78. PubMed ID: 30306591
[TBL] [Abstract][Full Text] [Related]
3. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.
Prat J;
Cancer; 2015 Oct; 121(19):3452-4. PubMed ID: 26110780
[TBL] [Abstract][Full Text] [Related]
4. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer.
Zeppernick F; Meinhold-Heerlein I
Arch Gynecol Obstet; 2014 Nov; 290(5):839-42. PubMed ID: 25082067
[TBL] [Abstract][Full Text] [Related]
5. [New FIGO classification of ovarian, fallopian tube and primary peritoneal cancer].
Höhn AK; Einenkel J; Wittekind C; Horn LC
Pathologe; 2014 Jul; 35(4):322-6. PubMed ID: 24899496
[TBL] [Abstract][Full Text] [Related]
6. Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013.
Prat J
Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):858-69. PubMed ID: 25890882
[TBL] [Abstract][Full Text] [Related]
7. Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal Cancers.
Matsuoka A; Tate S; Nishikimi K; Iwamoto M; Otsuka S; Shozu M
In Vivo; 2022; 36(5):2453-2460. PubMed ID: 36099140
[TBL] [Abstract][Full Text] [Related]
8. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum].
Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V
Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778
[TBL] [Abstract][Full Text] [Related]
9. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
Rosendahl M; Høgdall CK; Mosgaard BJ
Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
[TBL] [Abstract][Full Text] [Related]
10. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
11. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma.
Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Mikami M; Enomoto T; Katabuchi H; Aoki D
J Gynecol Oncol; 2020 Jul; 31(4):e45. PubMed ID: 32026659
[TBL] [Abstract][Full Text] [Related]
13. Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture.
Suh DH; Kim TH; Kim JW; Kim SY; Kim HS; Lee TS; Chung HH; Kim YB; Park NH; Song YS
J Gynecol Oncol; 2013 Oct; 24(4):352-8. PubMed ID: 24167671
[TBL] [Abstract][Full Text] [Related]
14. Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists.
Saida T; Tanaka YO; Matsumoto K; Satoh T; Yoshikawa H; Minami M
Jpn J Radiol; 2016 Feb; 34(2):117-24. PubMed ID: 26696400
[TBL] [Abstract][Full Text] [Related]
15. Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.
Bergsten TM; Burdette JE; Dean M
Cancer Lett; 2020 Apr; 476():152-160. PubMed ID: 32067992
[TBL] [Abstract][Full Text] [Related]
16. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.
Prat J;
Eur J Obstet Gynecol Reprod Biol; 2015 May; 188():133-5. PubMed ID: 25819291
[No Abstract] [Full Text] [Related]
17. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
18. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
[TBL] [Abstract][Full Text] [Related]
19. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.
Prat J; Belhadj H; Berek J; Bermudez A; Bhatla N; Cain J; Denny L; Fujiwara K; Hacker N; Avall-Lundqvist E; Mutch D; Odicino F; Pecorelli S; Quinn M; Seoud MA; Shrivastava SK;
Eur J Gynaecol Oncol; 2015; 36(4):367-9. PubMed ID: 26390684
[No Abstract] [Full Text] [Related]
20. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
[No Abstract] [Full Text] [Related]
[Next] [New Search]